[LGND] YoY Quarter Result on 30-Jun-2022 [#Q2]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
09-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- 94.18%
YoY- -102.91%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 41,531 26,366 57,419 84,675 41,420 24,987 90,043 -12.09%
PBT -65,390 3,171 -636 33,301 28,119 -18,028 95,579 -
Tax -13,479 881 259 2,576 6,033 -3,609 22,419 -
NP -51,911 2,290 -895 30,725 22,086 -14,419 73,160 -
Tax Rate - -27.78% - -7.74% -21.46% - -23.46% -
Total Cost 93,442 24,076 58,314 53,950 19,334 39,406 16,883 32.96%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin -124.99 8.69 -1.56 36.29 53.32 -57.71 81.25 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -2.88 0.13 -0.05 1.84 1.38 -0.74 3.45 -
EPS Diluted -2.88 0.13 -0.05 1.79 1.32 -0.74 2.99 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.